Citation Impact
Citing Papers
On the relationship between folding and chemical landscapes in enzyme catalysis
2008 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Inducible System in Human Hepatoma Cell Lines for Hepatitis C Virus Production
2002 StandoutNobel
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
2013
Management of hepatitis B
2007
A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection
2021
Targeting Hepatitis B Virus With CRISPR/Cas9
2014
Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection
2012
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Absolute binding free energy calculations: On the accuracy of computational scoring of protein–ligand interactions
2010 StandoutNobel
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
3D nanochannel electroporation for high-throughput cell transfection with high uniformity and dosage control
2015
AAV-Mediated Delivery of Zinc Finger Nucleases Targeting Hepatitis B Virus Inhibits Active Replication
2014
Antiviral drug-resistant HBV
2007
Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives
2008
Hepatitis B virus infection
2009 Standout
Highly Enantioselective Construction of a Chiral Tertiary Carbon Center by Alkynylation of a Cyclic N‐Acyl Ketimine: An Efficient Preparation of HIV Therapeutics
2003
Mechanical sensing of the penetration of various nanoneedles into a living cell using atomic force microscopy
2004
Advances in experimental systems to study hepatitis C virus in vitro and in vivo
2015
A review of non-nucleoside anti-hepatitis B virus agents
2014
Enantioselective rhodium-catalyzed addition of arylboronic acids to trifluoromethyl ketones
2006 StandoutNobel
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Hepatitis C Virus RNA Replication Depends on Specific Cis- and Trans-Acting Activities of Viral Nonstructural Proteins
2015
A binding free energy decomposition approach for accurate calculations of the fidelity of DNA polymerases
2009 StandoutNobel
Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease
2014
Predicting Drug‐Resistant Mutations of HIV Protease
2007 StandoutNobel
New Targets and Possible New Therapeutic Approaches in the Chemotherapy of Chronic Hepatitis B
2003
Chronic hepatitis B
2007 Standout
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
2015 Standout
Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir
2011 StandoutNobel
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Characterization of the Thermosensitive ts453 Reovirus Mutant: Increased dsRNA Binding of ς3 Protein Correlates with Interferon Resistance
1998
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNobel
Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
2013
A comprehensive examination of the contributions to the binding entropy of protein–ligand complexes
2010 StandoutNobel
Dual gRNAs guided CRISPR/Cas9 system inhibits hepatitis B virus replication
2015
Long-term hepatitis B infection in a scalable hepatic co-culture system
2017
Viral and cellular determinants involved in hepadnaviral entry
2007
Microneedles for drug and vaccine delivery
2012 Standout
Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant Variants
1996
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites
2011
Replicative Activity of Hepatitis B Virus Is Negatively Associated with Methylation of Covalently Closed Circular DNA in Advanced Hepatitis B Virus Infection
2011
A Double-blind Placebo-Controlled Study of Emtricitabine in Chronic Hepatitis B
2006
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
2003 Science
Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase
2013
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Validating the vitality strategy for fighting drug resistance
2011 StandoutNobel
Resistance to Alpha/Beta Interferons Correlates with the Epizootic and Virulence Potential of Venezuelan Equine Encephalitis Viruses and Is Determined by the 5′ Noncoding Region and Glycoproteins
1998
The Absence of Genital Human Papillomavirus DNA in Virginal Women
1992
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads
2003
Human immunodeficiency virus type 1 proteinase resistance to symmetric cyclic urea inhibitor analogs
1997
Converting structural information into an allosteric-energy-based picture for elongation factor Tu activation by the ribosome
2011 StandoutNobel
Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation
2012
Methodologic standards and contradictory results in case-control research
1979
Present and future therapies of hepatitis B: From discovery to cure
2015
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Surface modification of inorganic nanoparticles for development of organic–inorganic nanocomposites—A review
2013 Standout
Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L‐FMAU, DAPD, penciclovir and lobucavir
2000
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Apoptosis of Hepatitis B Virus-Infected Hepatocytes Prevents Release of Infectious Virus
2010
The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion
2015
Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450
1996
Toward Accurate Screening in Computer-Aided Enzyme Design
2009 StandoutNobel
MM-GB/SA Rescoring of Docking Poses in Structure-Based Lead Optimization
2008
THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS.
1964
On Catalytic Preorganization in Oxyanion Holes: Highlighting the Problems with the Gas-Phase Modeling of Oxyanion Holes and Illustrating the Need for Complete Enzyme Models
2010 StandoutNobel
PSI-7851, a Pronucleotide of β- d -2′-Deoxy-2′-Fluoro-2′- C -Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
2010
A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment
2010 Standout
Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA Formation
2007
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction
2009
Inhibition of Phosphorolysis Catalyzed by HIV-1 Reverse Transcriptase Is Responsible for the Synergy Found in Combinations of 3‘-Azido-3‘-deoxythymidine with Nonnucleoside Inhibitors
2005
Selection of Functional 5′ cis -Acting Elements Promoting Efficient Sindbis Virus Genome Replication
2003 StandoutNobel
Silver Nanoparticles Inhibit Hepatitis B virus Replication
2008
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
2012 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Noncompetitive Inhibition of Hepatitis B Virus Reverse Transcriptase Protein Priming and DNA Synthesis by the Nucleoside Analog Clevudine
2013
Detailed Computational Study of the Active Site of the Hepatitis C Viral RNA Polymerase to Aid Novel Drug Design
2013 StandoutNobel
Inhibition of Hepatitis C Replicon RNA Synthesis by β-D-2′-deoxy-2′-fluoro-2′-C-Methylcytidine: A Specific Inhibitor of Hepatitis C Virus Replication
2006
In Vitro Susceptibilities of Wild-Type or Drug-Resistant Hepatitis B Virus to (−)-β-d -2,6-Diaminopurine Dioxolane and 2′-Fluoro-5-Methyl-β-l -Arabinofuranosyluracil
2001
Nontoxic nanopore electroporation for effective intracellular delivery of biological macromolecules
2019 StandoutNobel
Works of Robert W. King being referenced
The Virion of Mengovirus Contains Anti-Interferon Activity
1993
Identification of a clinical isolate of HIV-1 with an isoleucine at position 82 of the protease which retains susceptibility to protease inhibitors
1995
Hep AD38 Assay: A High-Throughput, Cell-Based Screen for the Evaluation of Compounds Against Hepatitis B Virus
2003
Gene Delivery to Mammalian Cells by Microinjection
2004
Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication
2000
The M539V Polymerase Variant of Human Hepatitis B Virus Demonstrates Resistance to 2′-Deoxy-3′-Thiacytidine and a Reduced Ability to Synthesize Viral DNA
1998
Multiple Mutations in the Human Immunodeficiency Virus Protease Gene Are Responsible for Decreased Susceptibility to Protease Inhibitors
1995
The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues.
1998
Environmental variables related to cervical cancer
1962
A Cell-Based Model of HCV-Negative-Strand RNA Replication Utilizing a Chimeric Hepatitis C Virus/Reporter RNA Template
2002
Inhibition of Human Hepatitis B Virus Replication by AT-61, a Phenylpropenamide Derivative, Alone and in Combination with (−)β- l -2′,3′-Dideoxy-3′-Thiacytidine
1998
Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication
1997
The MN Gene MU, which Produces M and U but no N, S, or s*
1963
Potency of Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) Used in Combination with Other Human Immunodeficiency Virus NNRTIs, NRTIs, or Protease Inhibitors
2002